IDEAYA Biosciences Financials - Benzinga

SPY766.02 QQQ738.95+0.14%BTC/USD83,212.50−0.50%DIA514.74+0.36%GLD384.77+0.49%TLT78.73+0.64%

IDEAYA Biosciences Inc

IDYANASDAQ

Trade with Public

Trade with Public

$37.86

-0.36-0.94%

At close: Sep 28, 5:00 PM EST

$37.86

-0.36-0.94%

Pre-Market: 4:23 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

IDEAYA Biosciences Financials

IDEAYA Biosciences (IDYA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
IDEAYA Biosciences Q2 EPS $(1.22) Misses $(1.09) Estimate, Sales $8.857M Beat $5.015M Estimate

IDEAYA Biosciences (NASDAQ:IDYA) reported quarterly losses of $(1.22) per share which missed the analyst consensus estimate of $(1.09) by 11.93 percent. This is a 38.64 percent decrease over losses of $(0.88) per share

Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

PRO
IDEAYA Biosciences Q1 EPS $(1.11) Misses $(0.98) Estimate, Sales $6.560M Beat $5.008M Estimate

IDEAYA Biosciences (NASDAQ:IDYA) reported quarterly losses of $(1.11) per share which missed the analyst consensus estimate of $(0.98) by 13.27 percent. This is a 35.37 percent decrease over losses of $(0.82) per share

Benzinga Newsdesk

Stock Market Today: Dow Futures Fall As Trump Announces Strait Of Hormuz Blockade—Goldman Sachs, Fastenal In Focus (UPDATED)

Editor’s note: The future prices of benchmark tracking ETFs and pre-market prices of stocks have been updated. U.S. stock futures declined on Monday following Friday's mixed close. Futures of major benchmark indices were lower after President Donald Trump announced a blockade of the Strait of Hormuz.

Benzinga Neuro

Earnings Scheduled For February 17, 2026

Benzinga Insights

IDEAYA Biosciences Q4 Earnings Report: What Investors Need to Know

Benzinga Insights